Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.
Ozempic may significantly lower the risk of Alzheimer’s disease — here’s how
Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking skills and the ability to perform daily tasks.
Novo’s Semaglutide Linked to Reduced Alzheimer’s Risk in Real-World Study
Researchers have linked Novo Nordisk’s semaglutide to a 40% to 70% reduction in the risk of Alzheimer’s disease diagnosis in a study of medical records from 1 million patients.
Popular Weight Loss Drugs Ozempic, Wegovy May Lower Alzheimer's Disease Risk
Type-2 diabetes patients taking the active ingredient in the drugs, semaglutide, "had a significantly lower risk" of developing the disease, the study found
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study
The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may reduce the risk of Alzheimer's disease, a new study published Thursday finds.
More Evidence Ties Semaglutide to Reduced Alzheimer’s Risk
The GLP-1 RA semaglutide was associated with a 40%-70% reduced risk for first-time diagnosis of AD in patients with type 2 diabetes, real-world data show.
Novo’s Ozempic Linked to Reduced Alzheimer’s Diagnoses
Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according to new research that adds to the evidence surrounding the drug’s effects in diseases beyond type 2 diabetes and obesity.
Ozempic linked to lower Alzheimer’s risk in people with Type 2 diabetes
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal Alzheimer’s & Dementia.
Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
Semaglutide might help ward off Alzheimer’s disease, a new study says. Type 2 diabetics taking the drug had a lower risk of Alzheimer’s compared to patients on other diabetes
Ozempic linked to lower risk of Alzheimer’s diagnosis in observational study
In an observational study, Novo Nordisk’s drug Ozempic was linked to a lower risk of getting diagnosed with Alzheimer’s among people with type 2 diabetes.
STAT
15h
Pharmalittle: We’re reading about drug shortages, what drugmakers didn’t tell Alzheimer’s trial patients and more
By 2021, nearly 2,000 volunteers had answered the call to test an experimental
Alzheimer’s
drug known as BAN2401. For Eisai ...
News Medical
1h
Brain aging may hold the key to predicting Alzheimer’s risk
Research reveals advanced brain aging in older adults correlates with cognitive decline and Alzheimer's risk, highlighting ...
3h
Breakthrough Discovery: Freezing Alzheimer’s Progress by Pausing Amyloid Fibrils
Researchers have identified a key mechanism in the development of Alzheimer's disease involving the growth and pause of ...
3d
on MSN
Alzheimer's disease may damage the brain in two phases
Alzheimer's disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping ...
health enews
19h
Do’s and don’ts: Caring for a loved one with Alzheimer’s disease
When caring for a loved one with Alzheimer’s disease, be patient and repeat when necessary, plan ahead and use memory cues.
7d
on MSN
Alzheimer's disease might damage brain in two phases
Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly ...
WKBW
8h
Researchers at UB working to create vaccine to treat Alzheimer's disease
There have been many promising leads for an Alzheimer's vaccine but new treatments have been slow to merge. Researchers at ...
8h
Annual Alzheimer’s walk to be held in Ardmore Saturday
ARDMORE, Okla. (KXII) - Ardmore‘s annual Walk to End Alzheimer’s will be held Saturday. The event starts at 9:30 a.m. and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Novo Nordisk
Feedback